Ozempic vs Wegovy vs Mounjaro: Complete Comparison

Ozempic

Best for: Type 2 diabetes with weight benefit

Wegovy

Best for: Weight loss (higher dose semaglutide)

Mounjaro

Best for: Maximum weight loss (dual mechanism)

The Full Comparison

Feature	Ozempic	Wegovy	Mounjaro/Zepbound
Generic Name	semaglutide	semaglutide	tirzepatide
Mechanism	GLP-1 only	GLP-1 only	GLP-1 + GIP (dual)
FDA Indication	Type 2 diabetes	Weight management	Both (Mounjaro for diabetes, Zepbound for weight)
Max Dose	2.0 mg/week	2.4 mg/week	15 mg/week
Avg Weight Loss	~10-14%	~15-17%	~20-22%
Frequency	Weekly injection	Weekly injection	Weekly injection
Manufacturer	Novo Nordisk	Novo Nordisk	Eli Lilly
List Price	~$900-1,000/mo	~$1,300-1,400/mo	~$1,000-1,100/mo

Key Differences Explained

Ozempic vs Wegovy

Same drug (semaglutide), different doses and indications. Wegovy goes up to 2.4mg while Ozempic maxes at 2.0mg. If you have diabetes, Ozempic may be easier to get covered. If weight is the primary goal and you don't have diabetes, Wegovy is the indicated product.

Semaglutide vs Tirzepatide

The real comparison. Tirzepatide (Mounjaro/Zepbound) targets two receptors—GLP-1 and GIP—producing about 5% more weight loss on average. Head-to-head trials show tirzepatide outperforms semaglutide for both weight loss and blood sugar control. But both are highly effective.

Which Should You Choose?

If you have type 2 diabetes: Both work. Mounjaro may provide slightly better glucose control. Insurance coverage often determines the choice.

If weight loss is the primary goal: Tirzepatide (Zepbound) produces the most weight loss in trials. Wegovy is also highly effective and has longer track record.

If cost is the main concern: Whichever your insurance covers best. Or compounded versions of either active ingredient.

If you've tried one and it didn't work: Switching to the other mechanism (semaglutide → tirzepatide or vice versa) may produce better results.

The Bottom Line

Ozempic and Wegovy are the same drug (semaglutide) at different doses—Wegovy is specifically approved for weight loss at a higher dose. Mounjaro/Zepbound (tirzepatide) is a different drug with a dual mechanism that produces slightly more weight loss on average (~20% vs ~15-17%). All three are highly effective. The "best" choice depends on your specific situation: diabetes status, insurance coverage, and individual response. Many people do well on any of them.

Sources